Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate : GIMEMA CML Working Party analysis

収録刊行物

• J Clin Oncol.

  J Clin Oncol. 28 2748-2754, 2010